Calcimedica, INC. (CALC) — 8-K Filings

8-K Filings (17)

• 8-K Filing — Nov 6, 2025
• CalciMedica Files 8-K: Director Changes, Officer Appointments — Jun 27, 2025 Risk: medium
  On June 24, 2025, CalciMedica, Inc. filed an 8-K report detailing the election of new directors, the appointment of certain officers, and compensatory arrangeme
• CalciMedica Appoints PricewaterhouseCoopers as New Auditor — Jun 6, 2025 Risk: low
  On June 3, 2025, CalciMedica, Inc. filed an 8-K report indicating a change in its certifying accountant. The company has appointed PricewaterhouseCoopers LLP as
• CalciMedica Reports Material Agreement and Equity Sales — Mar 5, 2025 Risk: medium
  On February 28, 2025, CalciMedica, Inc. entered into a Material Definitive Agreement related to a direct financial obligation. The company also reported on the
• CalciMedica, Inc. Files 8-K Report — Mar 4, 2025 Risk: low
  On March 4, 2025, CalciMedica, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events. No specific financia
• CalciMedica Appoints Dr. Jonathan Lim to Board — Jan 14, 2025 Risk: low
  On January 10, 2025, CalciMedica, Inc. announced the election of Dr. Jonathan Lim to its Board of Directors. Dr. Lim, a seasoned executive with experience in th
• CalciMedica, Inc. Files 8-K Report — Dec 20, 2024 Risk: low
  On December 20, 2024, CalciMedica, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific mate
• CalciMedica Files 8-K on Financials — Nov 13, 2024 Risk: low
  On November 13, 2024, CalciMedica, Inc. filed an 8-K report detailing its results of operations and financial condition. The filing includes financial statement
• CalciMedica Appoints New CMO, Adds Directors — Nov 8, 2024 Risk: medium
  On November 6, 2024, CalciMedica, Inc. announced the appointment of Dr. Jonathan Lim as Chief Medical Officer and the election of Dr. Lim and Ms. Sarah P. Kelly
• CalciMedica, Inc. Files 8-K with Material Definitive Agreement — Oct 31, 2024 Risk: medium
  On October 30, 2024, CalciMedica, Inc. entered into a Material Definitive Agreement. The company also reported other events and filed financial statements and e
• CalciMedica, Inc. Files 8-K with Corporate Updates — Oct 30, 2024 Risk: low
  CalciMedica, Inc. filed an 8-K on October 30, 2024, reporting on various events. The filing includes information about the company's incorporation in Delaware,
• CalciMedica Appoints New CMO, Elects Director — Aug 27, 2024 Risk: medium
  CalciMedica, Inc. announced on August 27, 2024, the appointment of Dr. Robert J. Valeri as Chief Medical Officer and the election of Ms. Jennifer L. Jones to it
• CalciMedica Files 8-K: Reg FD, Other Events, Exhibits — Jun 27, 2024 Risk: low
  On June 27, 2024, CalciMedica, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing also includes Financial Statements and
• CalciMedica Changes Auditors to BDO USA, P.A. — Apr 10, 2024 Risk: low
  On April 5, 2024, CalciMedica, Inc. announced a change in its principal accounting firm, dismissing PricewaterhouseCoopers LLP and engaging BDO USA, P.A. as its
• CalciMedica, Inc. Files 8-K Report — Mar 29, 2024 Risk: low
  On March 29, 2024, CalciMedica, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating routine corporate disclosu
• CalciMedica Files 8-K Report on Feb 13, 2024 — Feb 13, 2024 Risk: low
  CalciMedica, Inc. filed an 8-K Current Report with the SEC on February 13, 2024. The filing indicates disclosures under Regulation FD, Other Events, and Financi
• CalciMedica Raises $5M in Private Placement of Stock & Warrants — Jan 22, 2024
  CalciMedica, Inc. (NASDAQ: CALC) announced on January 19, 2024, that it entered into a material definitive agreement, specifically a Securities Purchase Agreeme

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX